4th Aug 2026 11:35
(Alliance News) - The following are the leading risers and fallers among London Main Market small-cap and AIM stocks on Tuesday.
----------
Main Market small-cap winners
----------
Headlam Group PLC, up 22% at 8.96 pence
Gem Diamonds Ltd, up 13% at 3.79p
Synthomer PLC, up 9.4% at 97.40p, interim pretax loss narrows
Technology Minerals PLC, up 9.4% at 0.05p
RC365 Holding PLC, up 8.5% at 2.55p
----------
Main Market small-cap losers
----------
Solvonis Therapeutics PLC, down 11% at 0.13p
abrdn Property Income Trust Ltd, down 9.2% at 1.73p
Fragrant Prosperity Holdings Ltd, down 8.8% at 0.42p
CLS Holdings PLC, down 8.7% at 47.78p, issues profit warning on tenant exit and valuation fall
BSF Enterprise PLC, down 8.3% at 1.10p
----------
AIM winners
----------
FIH Group PLC, up 26% at 135.00 pence, sells Momart International division
MedPal AI PLC, up 16% at 3.60p, hits monthly record of NHS prescription items dispensed
GENinCode PLC, up 16% at 0.93p
Mendell Helium PLC, up 15% at 4.15p
Mercantile Ports & Logistics Ltd, up 15% at 1.95p
----------
AIM losers
----------
CT Automotive Group PLC, down 25% at 40.00p, interim pretax profit to be materially below prior year
Vulcan Two Group PLC, down 12% at 225.00p, sees near-term revenue hit
PACSCo Ltd, down 11% at 0.40p
Futura Medical PLC, down 9.7% at 0.36p
Active Energy Group PLC, down 8.8% at 0.08p
----------
Small-cap and AIM movers in focus:
----------
CLS Holdings PLC, down 8.7% at 47.78 pence, 12-month range 45.15p-67.00p. The property investor cuts its 2026 EPRA earnings guidance to 4.6p-5.5p per share from analyst consensus of 6.8p after slower-than-expected leasing, a key tenant opting not to extend its Spring Gardens lease, and a 4.6% fall in portfolio valuations. CLS expects first-half EPRA EPS of 2.7p and EPRA net tangible assets of 177.7p per share, but says its GBP100 million disposal programme and refinancing plans remain on track, with GBP62 million of asset sales completed and more than half of 2026 debt refinanced.
----------
Synthomer PLC, up 9.4% at 97.40 pence, 12-month range 16.70p-123.95p. The speciality chemicals firm says first-half results are ahead of expectations, driven by higher margins and cost savings, and now expects full-year 2026 performance to come in slightly ahead of market expectations. First-half revenue rises 6.7% to GBP954.3 million from GBP894.4 million a year earlier, while the pretax loss narrows to GBP25.5 million from GBP36.9 million and the basic loss per share improves to 3.1p from 25.5p.
----------
FIH Group PLC, up 26% at 135.00 pence, 12-month range 110.00p-330.00p. Agrees to sell loss-making fine art logistics business Momart for GBP7.6 million in cash, with the proceeds expected to be largely returned to shareholders and invested in its remaining Falkland Islands operations. The disposal, which is conditional on shareholder approval, represents a fundamental change of business under AIM rules. Momart reported an underlying pretax loss of GBP1.4 million in the year to March 31 and net assets of GBP2.1 million, with FIH saying the sale unlocks value amid challenging trading conditions.
----------
CT Automotive Group PLC, down 25% at 40.00 pence, 12-month range 19.00p-55.00p. The automotive interiors supplier says first-half underlying pretax profit will be materially below the prior year despite revenue rising 15% to USD62.1 million, as geopolitical instability lifted operating costs and disrupted supply chains. The company says higher freight costs, temporary inefficiencies at its expanding Mexico facility, and delayed cost recoveries weighed on earnings, though it expects materially stronger profitability in the second half alongside continued strong revenue growth. CT Automotive remains confident of meeting full-year market expectations as operational improvements and AI-driven factory systems boost efficiency.
----------
MedPal AI PLC, up 16% at 3.60 pence, 12-month range 2.00p-13.50p. Reports a record July across its NHS prescriptions, private prescriptions, and SaaS businesses, lifting its annualised recurring revenue run rate to more than GBP8.6 million from zero just nine months ago and up over 70% in the past two months. July saw a record 47,223 NHS prescription items dispensed, while its New Health GLP-1 clinic reached an annualised revenue run rate above GBP2.2 million after just three weeks of marketing. MedPal says all three revenue streams are recurring and expects further growth through cross-selling NHS pharmacy services and AI-powered health products to its expanding customer base.
----------
By Eva Castanedo, Alliance News senior economics reporter
Comments and questions to [email protected]
Copyright 2026 Alliance News Ltd. All Rights Reserved.
Related Shares:
Solvonis TherapAbrdn PropertyCLS HoldingsFragrant Prosp.Bio-Sustainable Future EnterprisesMedpal AIHeadlamGem Diamonds DiSynthomerTech MineralsRc365 HoldingFih GroupGenincodeMendell HeliumMercantile Ports & LogisticsCt AutomotiveVulcan TwoPacsco LimitedFutura MedicalActive Energy